Publications:

Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast.

Communications Biology

Nagasawa, Satoi S; Kuze, Yuta Y; Maeda, Ichiro I; Kojima, Yasuyuki Y; Motoyoshi, Ai A; Onishi, Tatsuya T; Iwatani, Tsuguo T; Yokoe, Takamichi T; Koike, Junki J; Chosokabe, Motohiro M; Kubota, Manabu M; Seino, Hibiki H; Suzuki, Ayako A; Seki, Masahide M; Tsuchihara, Katsuya K; Inoue, Eisuke E; Tsugawa, Koichiro K; Ohta, Tomohiko T; Suzuki, Yutaka Y

Publication Date: 2021-04-01

Variant appearance in text: NRAS: A155T

PubMed Link: 33795819

Variant Present in the following documents:

• 42003_2021_1959_MOESM10_ESM.xlsx, sheet 1

View BVdb publication page

Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung Cancer.

Cancers

Smolle, Elisabeth E; Taucher, Valentin V; Lindenmann, Joerg J; Jost, Philipp J PJ; Pichler, Martin M

Publication Date: 2021-02-09

Variant appearance in text: NRAS: A155T

PubMed Link: 33572278

Variant Present in the following documents:

• Main text
• cancers-13-00699.pdf

View BVdb publication page

Acquired resistance to targeted therapies in NSCLC: Updates and evolving insights.

Pharmacology & Therapeutics

Meador, Catherine B CB; Hata, Aaron N AN

Publication Date: 2020-06

Variant appearance in text: NRAS: A155T

PubMed Link: 32151666

Variant Present in the following documents:

• Main text

View BVdb publication page

NF1 mutations in conjunctival melanoma.

British Journal Of Cancer

Scholz, S L SL; Cosgarea, I I; Süßkind, D D; Murali, R R; Möller, I I; Reis, H H; Leonardelli, S S; Schilling, B B; Schimming, T T; Hadaschik, E E; Franklin, C C; Paschen, A A; Sucker, A A; Steuhl, K P KP; Schadendorf, D D; Westekemper, H H; Griewank, K G KG

Publication Date: 2018-05

Variant appearance in text: NRAS: 463G>A; Ala155Thr

PubMed Link: 29559732

Variant Present in the following documents:

• 41416_2018_46_MOESM4_ESM.xlsx, sheet 1

View BVdb publication page

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.

Cancer Discovery

Gainor, Justin F JF; Dardaei, Leila L; Yoda, Satoshi S; Friboulet, Luc L; Leshchiner, Ignaty I; Katayama, Ryohei R; Dagogo-Jack, Ibiayi I; Gadgeel, Shirish S; Schultz, Katherine K; Singh, Manrose M; Chin, Emily E; Parks, Melissa M; Lee, Dana D; DiCecca, Richard H RH; Lockerman, Elizabeth E; Huynh, Tiffany T; Logan, Jennifer J; Ritterhouse, Lauren L LL; Le, Long P LP; Muniappan, Ashok A; Digumarthy, Subba S; Channick, Colleen C; Keyes, Colleen C; Getz, Gad G; Dias-Santagata, Dora D; Heist, Rebecca S RS; Lennerz, Jochen J; Sequist, Lecia V LV; Benes, Cyril H CH; Iafrate, A John AJ; Mino-Kenudson, Mari M; Engelman, Jeffrey A JA; Shaw, Alice T AT

Publication Date: 2016-10

Variant appearance in text: NRAS: A155T

PubMed Link: 27432227

Variant Present in the following documents:

• Main text

View BVdb publication page